sentences:
The Value of a Regional Living COVID-19 Registry and the Challenges of Keeping It Alive BackgroundThe need for rapid access to regularly updated patient data for hypothesis testing, surge planning, and epidemiologic investigations underscore the value of updated registries that clinicians, researchers, and policy makers can easily access for local and regional planning. We sought to create an adaptive, living registry containing detailed clinical and epidemiologic and outcome data from SARS-CoV-2-PCR-positive patients in our healthcare system.

MethodsFrom 03/13/202 onward, demographics, comorbidities, outpatient medications, along with 75 laboratory, 2 imaging, 19 therapeutic, and 4 outcome-related parameters were manually extracted from the electronic medical record of SARS-CoV-2 positive patients. These parameters were entered on a registry featuring calculation, graphing tools, pivot tables, and a macro programming language. Initially, two internal medicine residents populated the database, then professional data abstractors populated the registry. When the National Center for Immunization and Respiratory Diseases released their COVID-19 case report form for public access, we adapted it and used it on a browser-based, metadata-driven electronic data capture software platform. Statistics were performed in R and Minitab.

ResultsAt the time of this submission, 200,807 SARS-CoV-2 RT-PCR tests were performed on 107,604 distinct patients. 3699 (3.4%) of those have had positive results. Of those, 399 (11%) have had the more than 75 parameters full entered in the registry. The average follow-up period was 25 days (range 21-34 days). Age, male gender, diabetes, hypertension, cardiovascular disease, kidney disease, and cancer were associated with hospital admission (all p values < 0.01), but not ICU admission. Statin, ACEI-ARB, and acid suppressant use were associated with admission (all p values < 0.03). Obesity and history of autoimmune disease were not associated with need for admission. Supplemental oxygen, vasopressor requirement, and outpatient statin use were associated with increased mortality (all p values < 0.03).

ConclusionA living COVID-19 registry represents a mechanism to facilitate optimal sharing of data between providers, consumers, health information networks, and health plans through technology-enabled, secure-access electronic health information. Our approach also involves a diversity of new roles in the field, such as using residents, staff, and the quality department, in addition to professional data extractors and the health informatics team.

However, due to the overwhelming number of infections that continues to accelerate, and the labor/time intense nature of the project, only 11% of all patients with COVID-19 had all parameters entered in the registry. Therefore, this report also offers lessons learned and discusses sustainability issues, should others wish to establish a registry. It also highlights the local and broader public health significance of the registry.


sentences: Continuous monitoring of SARS-CoV-2 RNA in urban wastewater from Porto, Portugal: sampling and analysis protocols Research on the emerging COVID-19 pandemic is demonstrating that wastewater infrastructures can be used as public health observatories of virus circulation in human communities. Important efforts are being organized worldwide to implement sewage-based surveillance of SARS-CoV-2 that can be used for preventive or early warning purposes, informing preparedness and response measures. However, its successful implementation requires important and iterative methodological improvements, as well as the establishment of standardized methods. The aim of this study was to develop a continuous monitoring protocol for SARS-CoV-2 in wastewater, that could be used to model virus circulation within the communities, complementing the current clinical surveillance. Specific objectives included (1) optimization and validation of a sensitive method for virus quantification; (2) monitoring the time-evolution of SARS-CoV-2 in wastewater from two wastewater treatment plants (WWTPs) in the city of Porto, Portugal. Untreated wastewater samples were collected weekly from the two WWTPs between May 2020 and March 2021, encompassing two COVID-19 incidence peaks in the region (mid-November 2020 and mid-January 2021). In the first stage of this study, we compared, optimized and selected a sampling and analysis protocol that included RNA virus concentration through centrifugation, RNA extraction from both liquid and solid fractions and quantification by reverse transcription quantitative PCR (RT-qPCR). In the second stage, we used the selected methodology to track SARS-CoV-2 in the collected wastewater over time. SARS-CoV-2 RNA was detected in 39 and 37 out of 48 liquid and solid fraction samples of untreated wastewater, respectively. The copy numbers varied throughout the study between 0 and 0.15 copies/ng RNA and a good fit was observed between the SARS-CoV-2 RNA concentration in the untreated wastewater and the COVID-19 temporal trends in the study region. In agreement with the recent literature, the results from this study support the use of wastewater-based surveillance to complement clinical testing and evaluate temporal and spatial trends of the current pandemic.

labels: epidemiology


sentences:
Utility of Automated Data-adaptive Propensity Score Method for Confounding by Indication in Comparative Effectiveness Study in Real World Medicare and Registry Data BackgroundConfounding by indication is a serious threat to comparative studies using real world data. We assessed the utility of automated data-adaptive analytic approach for confounding adjustment when both claims and clinical registry data are available.

MethodsWe used a comparative study example of carotid artery stenting (CAS) vs. carotid endarterectomy (CEA) in 2005-2008 when CAS was only indicated for patients with high surgical risk. We included Medicare beneficiaries linked to the Society for Vascular Surgerys Vascular Registry >65 years old undergoing CAS/CEA. We compared hazard ratios (HRs) for death while adjusting for confounding by combining various 1) Propensity score (PS) modeling strategies (investigator-specified [IS-PS] vs. automated data-adaptive [ada-PS]); 2) data sources (claims-only, registry-only and claims-plus-registry); and 3) PS adjustment approaches (matching vs. quintiles-adjustment with/without trimming). An HR of 1.0 was a benchmark effect estimate based on CREST trial.

ResultsThe cohort included 1,999 CAS and 3,255 CEA patients (mean age 76). CAS patients were more likely symptomatic and at high surgical risk, and experienced higher mortality (crude HR=1.82 for CAS vs. CEA). HRs from PS-quintile adjustment without trimming were 1.48 and 1.52 for claims-only IS-PS and ada-PS, 1.51 and 1.42 for registry-only IS-PS and ada-PS, and 1.34 and 1.23 for claims-plus-registry IS-PS and ada-PS, respectively. Estimates from other PS adjustment approaches showed similar patterns.

ConclusionsIn a comparative effectiveness study of CAS vs. CEA with severe confounding by indication, ada-PS performed better than IS-PS in general, but both claims and registry data were needed to adequately control for bias.


sentences:
Correcting COVID-19 PCR Prevalence for False Positives in the Presence of Vaccination Immunity Since the first analysis was published on 7 April 2021 the PCR test positivity rate has dropped significantly below the then estimated false positive rate (FPR) of 1.16% using the exponential decay to FPR model. Therefore, the estimate has been rejected and a new model was developed.

Using the ONS infection surveys assumption (PCR FPR rate below 0.1%) the new model splits the test time series data into two periods based on a change in transmissibility that coincides with the reopening of England schools on 8 March. The new model provides for two base levels of exponential decay (for each periods transmissibility) combined with a single decay rate increase dependent on vaccination.

Because the FPR is relatively insignificant compared to current PCR test positives, it cannot be statistically separated using currently available England epidemic time series data by the non-linear least squares estimation technique. Therefore, the FPR factor is temporarily dropped in the least squares regression.

The new model is stable in that it reasonably predicts through the most current available data (25 April) the future test prevalence using parameters estimated with 29 March data. Thus far, the estimate parameters remain within their original confidence intervals as successive days are added to the time series. Of potential usefulness is the current estimate for change in decay rate per mean vaccination rate, currently estimated at approximately 10.7% (CI: 8.8% - 12.6%). The estimate should be used with caution as other unforeseen factors could cause the model to misestimate.


sentences:
Silver diamine fluoride and oral-health related quality of life: A network meta-analysis ObjectiveSilver diamine fluoride (SDF) is an effective non-surgical treatment for dental caries which may also impact oral health-related quality of life (OHRQoL). The objective of this study was to conduct a network meta-analysis of SDF versus other standard of care therapies on OHRQoL.

Data SourcesStudies published in PubMed/MEDLINE, Scopus, or Web of Science through March 2021 with no date or language restrictions.

Study SelectionAny randomized controlled trial, cohort, or case-control study that included silver diamine fluoride as either a single or combinative treatment for dental caries and a quantitatively measured outcome for oral health-related quality of life was included.

Data Extraction and SynthesisPotentially eligible studies were screened by two independent reviewers trained in conducting systematic reviews. Studies meeting inclusion criteria underwent a full-text review with data being extracted using a standardized form, including publication details, study methodology, outcomes, assessors, and sample information. Studies underwent a risk of bias assessment and quality of evidence evaluation. Quantitative synthesis was performed using network meta-analysis.

Main Outcome(s) and Measure(s)Oral health-related quality of life.

Results19 articles were returned following search strategies. Following screening, ten studies were evaluated for full-text eligibility and five were retained for meta-analyses. Studies included in quantitative synthesis were classified as a high degree of evidence, suggesting estimated effects are similar to true effects. Direct and indirect estimates from network meta-analysis indicated that OHRQoL in children was not significantly different when treated with SDF versus atraumatic restorations (d = 0.02, 95% CI = -0.32, 0.36) or placebo (d = 0.03, 95% CI = -0.16, 0.22).

ConclusionsEvidence from the literature consistently shows no discernible impact on OHRQoL across various non-surgical treatments for dental caries. Overall oral health-related quality of life may increase regardless of treatment protocol due to treatment of the underlying disease. Concerns over the staining of dental decay and oral mucosa resulting from treatment with silver diamine fluoride do not seem to affect OHRQoL.


sentences:
Strain variation and anomalous climate synergistically influence cholera pandemics Explanations for the genesis and propagation of recurrent cholera pandemics since 1817 have remained elusive. Evolutionary change of the pathogen is presumed to have been a dominant factor behind the 7th "El Tor" pandemic, but little is known to support this hypothesis for preceding pandemics. We investigate the concomitant roles of climate and putative strain variation for the 6th cholera pandemic (1899-1923; the one with the highest ever associated mortality in India), using newly assembled historical records for climate variables and cholera deaths for Bengal, Assam, Bihar and Bombay provinces in former British India. We compare this historical pandemic with the 7th (El Tor) one and with the temporary emergence of the O139 strain in Bangladesh and globally. Finally, we ran multi-model climate simulations to infer past and future long-term means of rainfall distributions on the basis of 39 models for 1861-2100, and for different periods of 50 years (1875-1925; 1975-2025 and 2050-2100).

The 6th cholera pandemic featured a large scale synchronisation with a delay of a few years in both seasonal and interannual cholera variability over the endemic Bengal region during the El Nino event of 1904-07. Additional evidence supporting the establishment of a new strain includes a shift of cholera incidence to older age groups, an increase in the case fatality rate and the suppression of the spring cholera peak.

The 6th cholera pandemic of Indian origin was associated with a novel and particularly invasive strain of new territory, and also with some delay, of endemic parts of India that act as a genetic regional reservoir of the disease. Climate anomalies appear to have played an important role in facilitating the establishment of this invasive strain, with environmental conditions similar to those underlying strain changes associated with ENSO in todays Bangladesh. The evolutionary change of pathogens can act synergistically with climatic conditions in the replacement and propagation of emerging strains, as was the case in choleras 7th pandemic. Increased climate variability and extremes under global warming would thus provide windows of opportunity for emerging new pathogens.


sentences: Characterising contact in disease outbreaks via a network model of spatial-temporal proximity Contact tracing is a key tool in epidemiology to identify and control outbreaks of infectious diseases. Existing contact tracing methodologies produce contact maps of individuals based on a binary definition of contact which can be hampered by missing data and indirect contacts. Here, we present a Spatial-temporal Epidemiological Proximity (StEP) model to recover contact maps in disease outbreaks based on movement data. The StEP model accounts for imperfect data by considering probabilistic contacts between individuals based on spatial-temporal proximity of their movement trajectories, creating a robust movement network despite possible missing data and unseen transmission routes. Using real-world data we showcase the potential of StEP for contact tracing with outbreaks of multidrug-resistant bacteria and COVID-19 in a large hospital group in London, UK. In addition to the core structure of contacts that can be recovered using traditional methods of contact tracing, the StEP model reveals missing contacts that connect seemingly separate outbreaks. Comparison with genomic data further confirmed that these recovered contacts indeed improve characterisation of disease transmission and so highlights how the StEP framework can inform effective strategies of infection control and prevention.


sentences:
Social, demographic and behavioural determinants of SARS-CoV-2 infection: A case-control study carried out during mass community testing of asymptomatic individuals in South Wales, December 2020 BackgroundBetween 21 November and 22 December 2020, a SARS-CoV-2 community testing pilot took place in the South Wales Valleys. Lateral flow tests were offered to all people aged over 10 years living, studying or working in the area.

MethodsWe conducted a case-control study in adults taking part in the pilot using an anonymous online questionnaire. Social, demographic and behavioural factors were compared in people with a positive test (cases) and a sample of negatives (controls). Population attributable fractions (PAF) were calculated for factors with significantly increased odds following multivariate analysis.

ResultsA total of 199 cases and 2,621 controls were recruited by SMS (response rates: 27.1% and 37.6% respectively). Following adjustment, cases were more likely to work in the hospitality sector (aOR: 3.39, 95% CI: 1.43-8.03), social care (aOR: 2.63, 95% CI: 1.22-5.67) or healthcare (aOR: 2.31, 95% CI: 1.29-4.13), live with someone self-isolating due to contact with a case (aOR: 3.07, 95% CI: 2.03-4.62), visit a pub (aOR: 2.87, 95% CI: 1.11-7.37), and smoke or vape (aOR: 1.54, 95% CI: 1.02-2.32). In this community, and at this point in the epidemic, reducing transmission from a household contact who is self-isolating would have the biggest public health impact (PAF: 0.2).

ConclusionInfection prevention and control should be strengthened to help reduce household transmission. As restrictions on social mixing are relaxed, hospitality venues will become of greater public health importance, and those working in this sector should be adequately protected. Smoking or vaping may be an important modifiable risk factor.

What is already known on this subject?Certain populations are known to be at risk of severe COVID-19: Older people, males, people in minority ethnic groups, people with pre-existing chronic disease or disability, and people in certain public-facing occupations. However, limited information exists on the factors associated with acquiring SARS-CoV-2 in the community.

What this study adds?This study provides an insight into the most important factors determining community transmission of SARS-CoV-2. We found that transmission within the household was the most important source of SARS-CoV-2 infection. Working in the hospitality sector, and visiting the pub were associated with infection but at the time of this study were relatively infrequent exposures. Smoking or vaping had a small but significant effect. Working in education, living with someone working in education, having caring responsibilities, attending a healthcare appointment and visiting a supermarket, restaurant, gym or leisure centre were not associated with infection. Whilst these findings relate to a specific community at a specific time in the course of the epidemic when social restrictions were in place, the information will be useful in supporting policy decisions. Mass testing exercises present an opportunity to conduct epidemiological studies to gather information to inform the local and national epidemic response.


sentences: Evaluating and optimizing COVID-19 vaccination policies: a case study of Sweden We evaluate the efficiency of vaccination scenarios for COVID-19 by analysing a data-driven mathematical model. Healthcare demand and incidence are investigated for different scenarios of transmission and vaccination schemes. Our results suggest that reducing the transmission rate affected by invading virus strains, seasonality and the level of prevention, is most important. Second to this is timely vaccine deliveries and expeditious vaccination management. Postponing vaccination of antibody-positive individuals reduces also the disease burden, and once risk groups have been vaccinated, it is best to continue vaccinating in a descending age order.

labels: public and global health


sentences:
Material properties of urethral stents for hypospadias repair IntroductionDespite the prevalence of hypospadias surgery and the near ubiquitous use of postoperative urethral stents, there has been no evaluation of the material properties of commonly used choices. Our study sets out to close this gap with an evaluation and comparison of the material properties of four urethral stents commonly used after hypospadias surgery.

Study DesignThermal analysis and mechanical analysis of the Zaontz Urethral Stent, the Firlit-Kluge Urethral Stent, the Koyle Diaper Stent, and the Bard Premature Infant Feeding Tube were performed.

ResultsThermal analysis shows that all four compositions tested are rubbery polymers at body temperature, with glass transition temperatures far below human body temperatures. The Zaontz and Koyle stents are thermoplastic elastomers with strong melting transitions above body temperature, but the Firlit-Kluge stent is completely amorphous at body temperature and is likely chemically cross-linked to generate the polymer network. The Bard feeding tube was by far the stiffest, with a Youngs Modulus of 14.0{+/-} 0.78 (compared to the Zaontz stent at 4.12 {+/-} 0.56, the Firlit-Kluge stent at 4.92{+/-} 0.63, and the Koyle stent at 4.09{+/-} 0.49.) The Firlit-Kluge stent was the strongest, with 84.3{+/-} 2.83 MPa required to fracture it compared to the Zaontz stent at 65.5 {+/-} 2.57, the Koyle stent at 66.8{+/-} 3.16, and then Bard feeding tube at 34.6{+/-} 1.89.

DiscussionWhile there is little information associating urethral stent type with outcomes after hypospadias surgery, material properties may account for findings of prior studies. Stiffer stents may contribute to decreased postoperative comfort, while a stent that is too soft and extensible may have issues with dislodgement, kinking and breaking.

ConclusionThis study provides a foundation for future work optimizing urethral stents, designing support for regenerative medicine applications, and improving hypospadias outcomes.

labels: urology


sentences: Identifiability and Predictability of Integer- and Fractional-Order Epidemiological Models Using Physics-Informed Neural Networks We analyze a plurality of epidemiological models through the lens of physics-informed neural networks (PINNs) that enable us to identify multiple time-dependent parameters and to discover new data-driven fractional differential operators. In particular, we consider several variations of the classical susceptible-infectious-removed (SIR) model by introducing more compartments and delay in the dynamics described by integer-order, fractional-order, and time-delay models. We report the results for the spread of COVID-19 in New York City, Rhode Island and Michigan states, and Italy, by simultaneously inferring the unknown parameters and the unobserved dynamics. For integer-order and time-delay models, we fit the available data by identifying time-dependent parameters, which are represented by neural networks (NNs). In contrast, for fractional differential models, we fit the data by determining different time-dependent derivative orders for each compartment, which we represent by NNs. We investigate the identifiability of these unknown functions for different datasets, and quantify the uncertainty associated with NNs and with control measures in forecasting the pandemic.

labels: infectious diseases


sentences: Imputation strategies for missing baseline neurological assessment covariates after traumatic brain injury: A CENTER-TBI study Statistical models for outcome prediction are central to traumatic brain injury research and critical to baseline risk adjustment. Glasgow coma score (GCS) and pupil reactivity are crucial co-variates in all such models but may be measured at multiple time points between the time of injury and hospital and are subject to a variable degree of unreliability and/or missingness. Imputation of missing data may be undertaken using full multiple imputation or by simple substitution of measurements from other time points. However it is unknown which strategy is best or which time points are more predictive. We evaluated the pseudo-R2 of logistic regression models (dichotomous survival) and proportional odds models (Glasgow Outcome Score-extended) using different imputation strategies from data from the The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. Substitution strategies were easy to implement, achieved low levels of missingness (<< 10%) and could outperform multiple imputation without the need for computationally costly calculations and pooling multiple final models. Model performance was sensitive to imputation strategy although this was small in absolute terms and clinical relevance. A strategy of using the emergency department discharge assessments and working back in time when these were missing generally performed well. Full multiple imputation had the advantage of preserving time-dependence in the models: The pre-hospital assessments were found to be relatively unreliable predictors of survival or outcome. The predictive performance of later assessments was model-dependent. In conclusion, simple substitution strategies for imputing baseline GCS and pupil response can perform well and may be a simple alternative to full multiple imputation in many cases.


sentences:
Companionship for women using English maternity services during COVID-19: National and organisational perspectives ObjectivesTo explore the impact of COVID-19 on companionship for women using maternity services in England, as part of the Achieving Safe and Personalised maternity care In Response to Epidemics (ASPIRE COVID-19 UK) study.

SettingMaternity care provision in England.

ParticipantsInterviews were held with 26 national governmental, professional, and service-user organisation leads including representatives from the Royal College of Midwives, NHS England, Birthrights and AIMS (July-Dec). Other data included public-facing outputs logged from 25 maternity Trusts (Sept/Oct) and data extracted from 78 documents from 8 key governmental, professional and service-user organisations that informed national maternity care guidance and policy (Feb-Dec).

ResultsSix themes emerged:  Postcode lottery of care highlights variations in companionship practices,  Confusion and stress around  rules relates to a lack of and variable information concerning companionship,  Unintended consequences concerns the negative impacts of restricted companionship on service-users and staff,  Need for flexibility highlights concerns about applying companionship policies irrespective of need,   Acceptable time for support highlights variations in when and if companionship was  allowed antenatally and intrapartum; and  Loss of human rights for gain in infection control emphasizes how a predominant focus on infection control was at a cost to psychological safety and womens human rights.

ConclusionsPolicies concerning companionship have been inconsistently applied within English maternity services during the COVID-19 pandemic. In some cases, policies were not justified by the level of risk, and were applied indiscriminately regardless of need. This was associated with psychological harms for some women and staff. There is an urgent need to determine how to balance risks and benefits sensitively and flexibly and to optimise outcomes during the current and future crisis situations.

Strengths and limitations of this studyO_LIThis is the first paper to consider links between policy and practice in companionship in maternity care during the COVID-19 pandemic;
C_LIO_LIData triangulation across stakeholders, policy and practice provides nuanced and context related perspectives on why and how companionship was impacted;
C_LIO_LIStakeholders included representatives from all key agencies involved in maternity care;
C_LIO_LIPractice related issues were collected from the maternity Trust website and social media-based public facing information, which may or may not reflect actual care practices;
C_LIO_LIThe study does not include information directly reported by parents and healthcare professionals.
C_LI

labels: health systems and quality improvement


sentences:
Milestone Development in Genetic Conditions from SFARI Registries BackgroundSeveral recent initiatives have sought to better understand characteristic behaviors of rare genetic conditions associated with autism spectrum disorder (ASD). The onset of developmentally expected skills, such as walking and talking, serve as readily quantifiable aspects of the behavioral phenotype. The goals of this study were to describe attainment of major motor and language milestones in genetic conditions implicated in the etiology of ASD and other neurodevelopmental disorders and to compare those phenotypes to idiopathic ASD.

MethodsParticipants ages 3 years and older were drawn from two Simons Foundation Autism Research Initiative-funded registries with consistent phenotyping protocols. Inclusion criteria consisted of a confirmed genetic diagnosis for one of 16 specific genetic conditions (Simons Searchlight), and absence of pathogenic genetic findings in idiopathic ASD controls (SPARK). Parent-reported age of acquisition of three motor and two language milestones was described and quantified as on-time or delayed relative to normative expectations.

ResultsDelay was more common among participants with rare genetic conditions than idiopathic ASD for all milestones. Compared to the idiopathic ASD group, the median odds of delay among the genetic groups were 8.3 times (IQR 5.8-16.3) higher for sitting, 12.4 times (IQR 5.3-19.5) higher for crawling, 26.8 times (IQR 7.7-41.1) higher for walking, 2.7 times (IQR 1.7-5.5) higher for single words, and 5.7 times (IQR 2.8-18.3) higher for combined words.

ConclusionDelays in major developmental milestones, particularly in motor skills, may be among the earliest clues that developmental processes may be differentially affected in specific genetically defined conditions versus a behaviorally defined disorder such as idiopathic ASD.

labels: psychiatry and clinical psychology


sentences:
Lung proteomic biomarkers associated with chronic obstructive pulmonary disease BackgroundIdentifying protein biomarkers for chronic obstructive pulmonary disease (COPD) has been challenging. Most previous studies have utilized individual proteins or pre-selected protein panels measured in blood samples. Mass spectrometry proteomic studies of lung tissue have been based on small sample sizes.

MethodsWe utilized mass spectrometry proteomic approaches to discover protein biomarkers from 150 lung tissue samples representing COPD cases and controls. Top COPD-associated proteins were identified based on multiple linear regression analysis with false discovery rate (FDR) < 0.05. Correlations between pairs of COPD-associated proteins were examined. Machine learning models were also evaluated to identify potential combinations of protein biomarkers related to COPD.

ResultsWe identified 4407 proteins passing quality controls. Twenty-five proteins were significantly associated with COPD at FDR < 0.05, including Interleukin 33, Ferritin (light chain and heavy chain), and two proteins related to caveolae (CAV1 and CAVIN1). Multiple previously reported plasma protein biomarkers for COPD were not significantly associated with proteomic analysis of COPD in lung tissue, although RAGE was borderline significant. Eleven pairs of top significant proteins were highly correlated (r > 0.8), including several strongly correlated with RAGE (EHD2 and CAVIN1). Machine learning models using Random Forests with the top 5% of protein biomarkers demonstrated reasonable accuracy (0.766) and AUC (0.702) for COPD prediction.

ConclusionsMass spectrometry proteomic analysis of lung tissue is a promising approach for the identification of biomarkers for COPD.

labels: respiratory medicine


sentences: A rare congenital anemia is caused by mutations in the centralspindlin complex Congenital dyserythropoietic anemias (CDAs) are rare disorders characterized by morphologic abnormalities of erythroid precursors leading to ineffective erythropoiesis. CDA type III (CDAIII), characterized by erythroblast multinucleation, represents the rarest form with only [~]60 patients described in the literature. Previous work, studying two independent families, identified a causative dominant missense mutation in KIF23, which encodes for the kinesin MKLP1. Here, we describe a sporadic CDAIII case associated with compound heterozygous variants in RACGAP1, a gene not previously associated with any disease. RACGAP1 encodes CYK4, a GTPase activating protein (GAP) for Rho-family GTPases, which interacts with MKLP1 to form the centralspindlin complex. Functional assays show these RACGAP1 variants cause cytokinesis defects due, at least in part, to altering the substrate specificities of the GAP activity of CYK4. These findings provide novel insights into the structural determinants of the GAP activity and demonstrates that cytokinesis failure due to centralspindlin defects leads to CDAIII. Our findings highlight the importance of viewing diseases as malfunctions of common biological pathways/complexes and suggests that next-generation sequencing analysis pipelines should integrate a systems approach in order to identify such functionally related variants.

labels: genetic and genomic medicine


sentences: Covid-19 and Excess Mortality in Medicare Beneficiaries We estimated excess mortality in Medicare recipients with probable and confirmed Covid-19 infections in the general community and amongst residents of long-term care (LTC) facilities. We considered 28,389,098 Medicare and dual-eligible recipients from one year before February 29, 2020 through September 30, 2020, with mortality followed through November 30th, 2020. Probable and confirmed Covid-19 diagnoses, presumably mostly symptomatic, were determined from ICD-10 codes. We developed a Risk Stratification Index (RSI) mortality model which was applied prospectively to establish baseline mortality risk. Excess deaths attributable to Covid-19 were estimated by comparing actual-to-expected deaths based on historical comparisons and in closely matched cohorts with and without Covid-19. 677,100 (2.4%) beneficiaries had confirmed Covid-19 and 2,917,604 (10.3%) had probable Covid-19. 472,329 confirmed cases were community living and 204,771 were in LTC. Mortality following a probable or confirmed diagnosis in the community increased from an expected incidence of about 4% to actual incidence of 7.5%. In long-term care facilities, the corresponding increase was from 20.3% to 24.6%. The absolute increase was therefore similar at 3-4% in the community and in LTC residents. The percentage increase was far greater in the community (89%) than among patients in chronic care facilities (21%) who had higher baseline risk. The LTC population without probable or confirmed Covid-19 diagnoses experienced 38,932 excess deaths (35%) compared to historical estimates. Limitations in access to Covid-19 testing and disease under-reporting in LTC patients probably were important factors, although social isolation and disruption in usual care presumably also contributed. Remarkably, there were 31,360 fewer deaths than expected in community dwellers without probable or confirmed Covid-19 diagnoses, representing a 6% reduction. Disruptions to the healthcare system and avoided medical care were thus apparently offset by other factors, representing overall benefit. The Covid-19 pandemic had marked effects on mortality, but the effects were highly context-dependent.

labels: health informatics


sentences:
Developing a Community Engaged Sickle Cell Disease Center: An Initial Data Analysis of Healthcare Utilization Rates and Perspectives of Key Informants. BackgroundThe mortality rate of individuals with Sickle cell disease (SCD), the most prevalent genetic disease in the United States, has been increasing at 1% per year. It has been declared a global and national public health priority by the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC). As a complex chronic and acute condition, preventive care and patient management of SCD requires a patient-centered, comprehensive, and multidisciplinary approach; unfortunately, few SCD treatment centers use this approach. Moreover, individuals with SCD are at the intersectionality of race and socioeconomics and thus face additional barriers to access to quality care, which may ultimately result in higher utilization of acute care services, especially during the transitioning period from pediatric to adult care. Greater acute care utilization has been found to be associated with higher mortality rate and severely compromised health related quality of life; thus, it is important to assessing needs of SCD patients as they relate to access to quality care.

ObjectiveThe aim of this study was to conduct a preliminary needs assessment for the development of a community engaged SCD center. This study also aimed to determine if frequency of acute care utilization was associated with age and insurance type, to provide surveillance data, and to identify opportunities to address barriers to access to quality care from key informant (local and cross-institutional) perspectives.

MethodA retrospective cohort study of SCD related emergency department (ED), inpatient hospitalization, and outpatient clinic utilization encounters, which occurred from 09/01/2012-06/01/2019, was queried from UF Healths Integrated Data Repository (IDR). Quantitative analysis, frequencies, proportions, and Pearson Chi-square inference were conducted on the administrative data received. Further, key informant interviews of stakeholders in Alachua County, FL and Yale New Haven Healths Adult Sickle Cell Program, New Haven, CT were performed. An iterative qualitative thematic analysis of their perspectives was conducted.

ResultThere were 27,932 total encounters that were stratified by age and payer type. The average length of hospitalization stay was .71 {+/-} 3.84. The 18-30-year-olds had the highest proportion of ED utilization (34.7%), hospitalizations (32.1%), and outpatient clinic utilization (26.4%). This was followed by the 31-45-year-olds with 20.4% of ED utilizations, 22% of hospitalizations, and 20.5% of outpatient clinic utilizations. Those with public health insurance accounted for 74% of ED encounters, 81% of hospitalizations, and 82% of outpatient encounters. Common themes and subthemes from key informant interviews included: champion, transition of care, pain management, bias, patient and family education, provider knowledge, social worker, multidisciplinary/comprehensive care, mental health, education, and employment.

ConclusionAmong adults with SCD in the UF Health system, younger adults (e.g., those who are transitioning into adult care) and those with public insurance utilized acute care services at greater proportions, indicating a need to identify and address possible barriers to access to quality care.

labels: hematology


sentences:
Metabolomics strategy for diagnosing urinary tract infections Metabolomics has emerged as a mainstream approach for investigating complex metabolic phenotypes. Despite its obvious suitability to diagnostics, it has yet to be integrated into routine clinical laboratory applications. Metabolomics-based diagnosis of infectious diseases is a logical application of this technology since microbial metabolic waste products are concentrated at the site of infection. In the case of urinary tract infections (UTIs), one of the most common bacterial infections, microbial catabolites are trapped in the bladder and thus could enable rapid diagnosis of UTIs. We conducted an untargeted metabolomics screen of 110 clinical specimens and identified two metabolites, agmatine and N6-methyladenine, that are predictive of a wide transect of pathogen species that collectively account for over 90% of UTI infections. We showed that these metabolites were consistently observed in multiple independent cohorts, including a blinded trial of over 587 clinical specimens (95% sensitivity, 86% specificity; PPV, 0.68; NPV, 0.98). These findings demonstrate the potential utility of metabolomics for diagnosing infectious diseases. Moreover, the rapid analysis times enabled through our metabolomics diagnostic approach--six minutes per sample--could curtail the inappropriate UTI clinical prescribing practices that are currently contributing to the selection of antimicrobial resistance.

Significance statementWe show that a six-minute metabolomics assay robustly identifies most UTIs based on the presence of two microbial catabolites present in the urine. We demonstrate the potential clinical utility of this strategy in a prospective blinded trial. If implemented in clinical practice, this diagnostic approach could shorten laboratory testing times for UTIs by 18 hours and could improve antimicrobial stewardship.


sentences:
Antibody Responses in Elderly Residential Care Persons following COVID-19 mRNA Vaccination ObjectiveCOVID-19 disproportionately impacts older adults residing at long-term care facilities. Data regarding antibody response to COVID-19 vaccines in this population is limited. Our objective was to quantify the presence and magnitude of antibody response in older, vaccinated residents at assisted living, personal care, and independent living facilities.

DesignA cross-sectional quality improvement study was conducted March 15 - April 1, 2021 in the Pittsburgh region.

Setting and PopulationParticipants were volunteers at assisted living, personal care, and independent living facilities, who received mRNA COVID-19 vaccine. Conditions that obviate immune responses were exclusionary criteria.

MethodsSera were collected to measure IgG anti-SARS-CoV-2 antibody level with reflex to total anti-SARS-CoV-2 immunoglobulin levels. Descriptive statistics, Pearson correlation coefficients, and multiple linear regression analysis were performed to evaluate relationships between factors potentially associated with antibody levels.

ResultsAll participants (N=70) had received two rounds of vaccination for COVID-19 and were found to have antibodies to SARS-CoV-2. There was wide variation in relative levels of antibodies as determined by extinction coefficients. Antibody levels trended lower in male sex, advanced age, steroid medications, and longer length of time from vaccination.

Conclusions and ImplicationsHigher functioning long-term care residents mounted detectable antibody responses when vaccinated with COVID-19 mRNA-based vaccines. This study provides preliminary information on level of population risk of assisted living, personal care, and independent living residents which can inform reopening strategies. Data suggests some degree of immunity is present during the immediate period following vaccination. However, protective effects of such vaccination programs remain to be determined in larger studies. Clinical protection is afforded not just by pre-formed antibody levels, but by ongoing adaptive immunity, which is known to be decreased in older individuals. Thus, the implications of these levels of antibodies in preventing COVID-19 disease must be determined by clinical follow-up.

labels: allergy and immunology


sentences:
Cardiac Surgery during the Covid-19 Pandemic: Evidence from the first wave BackgroundThe Covid-19 pandemic has affected human behaviour and burdened health systems and has thus had an impact on other health outcomes.

ObjectiveThis paper studies whether there was a decrease in cardiac surgery operations in Greece during the first wave of the Covid-19 pandemic.

Data and MethodsWe used data from 7 major hospitals that geographically cover about half the country and more than half the population, including a mix of public, private, military and childrens hospitals. We used a difference-in-differences econometric approach to compare trends in cardiac surgery before and after the pandemic in 2020, to the same months in 2019, controlling for seasonality and unemployment, and using hospital fixed effects.

ResultsWe found that during the first wave of the pandemic and the associated lockdown, there were 35-56% fewer cardiac surgery operations compared to what we would have expected in the absence of the pandemic.

ConclusionsThere was a steep decline in Cardiac surgery operations in Greece during the first wave of the Covid-19 pandemic. Possible reasons may include people not seeking medical attention to avoid the risk of catching Covid-19; fewer referrals; and working from home, thus not being exposed to a stressful work environment or commute.

labels: cardiovascular medicine


sentences:
CVA-Flow novel telestroke system preliminary trial: reliability in determining NIHSS for acute ischemic stroke BackgroundThe National Institutes of Health Stroke Scale (NIHSS) is the most recommended tool for objectively quantifying the impairment caused by a suspected stroke. Nevertheless, it is used almost solely by trained neurologists in the emergency departments (ED) setting. CVA-Flow (CVAid medical Ltd., Tel-Aviv, Israel) is a smartphone-based Telestroke system that captures the full NIHSS by video and enables a distant stroke physician to assess the patients neurological status, bringing forward the NIHSS to the pre-hospital setting.

ObjectiveWe aimed to compare the reliability of an NIHSS score determined by a neurologist from afar, using the CVA-Flow platform, with a standard NIHSS assessment performed in the ED).

MethodsIn this multi-center prospective trial, Patients admitted to the ED in Rambam hospital in Haifa, Israel, and Vall dHebron hospital (VdH) in Barcelona, Spain, had a neurological exam based on the NIHSS while being recorded by the system. A neurologist blinded to the results rated the NIHSS according to the videos offline.

ResultsA total of 95 patients with a suspected stroke were included. Overall ICC was 0.936 (0.99 in VdH and 0.84 in Rambam), indicating excellent and good reliability, respectively.

ConclusionRemote stroke assessment based on the NIHSS, using videos collected by the CVA-Flow platform, installed on a standard smartphone, is a reliable measurement as compared with bedside evaluation.

labels: emergency medicine


sentences:
Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study. Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) and nonalcoholic steatohepatitis (NASH). In the U.S., Hispanics (HIS) are afflicted with NAFLD at a higher rate and severity compared to other ethnicities. To date, the mechanisms underlying this disparity have not been elucidated. In this pilot study, we compared untargeted plasma metabolomic profiles for primary metabolism, complex lipids, choline and related compounds between a group of HIS (n =7) and White Caucasian (CAU, n =8) subjects with obesity and biopsy-characterized NAFL to ethnicity-matched lean healthy controls (n =14 HIS and 8 CAU). We also compared liver and plasma metabolomic profiles in a group of HIS and CAU subjects with obesity and NASH of comparable NAFLD Activity Scores, to BMI-matched NASH-free subjects in both ethnicities. Results highlight signs of metabolic dysregulation observed in HIS, independent of obesity, including higher plasma triglycerides, acylcarnitines, and free fatty acids. With NASH progression, there were ethnicity-related differences in the hepatic profile, including higher free fatty acids and lysophospholipids seen in HIS, suggesting lipotoxicity is involved in the progression of NASH. We also observed greater hepatic triglyceride content, higher plasma triglyceride concentrations and lower hepatic phospholipids with signs of impaired hepatic mitochondrial {beta}-oxidation. These findings provide preliminary evidence indicating ethnicity-related variations that could potentially modulate the risk for progression of NALD to NASH.

HighlightsO_LIHispanic subjects show signs of metabolic dysregulations independent of obesity.
C_LIO_LIIn nonalcoholic fatty liver, plasma metabolomic profiles are differentially altered between ethnicities.
C_LIO_LIIn nonalcoholic steatohepatitis, the hepatic lipidomic profiles are differentially altered between ethnicities.
C_LIO_LIIn Hispanics, nonalcoholic steatohepatitis shows higher triglycerides and lipotoxic lipids with signs of impaired hepatic mitochondrial {beta}-oxidation.
C_LIO_LIOur results indicate evidence of ethnicity-related variations in the pathogenesis of nonalcoholic fatty liver disease.
C_LI

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=103 HEIGHT=200 SRC="FIGDIR/small/21254907v1_ufig1.gif" ALT="Figure 1">
View larger version (35K):
org.highwire.dtl.DTLVardef@232953org.highwire.dtl.DTLVardef@6e3660org.highwire.dtl.DTLVardef@1b3f698org.highwire.dtl.DTLVardef@28256_HPS_FORMAT_FIGEXP  M_FIG C_FIG

labels: endocrinology


sentences:
Reflections of COVID-19 cases on the wastewater loading of SARS-CoV-2 RNA: A case of three major cities of Gujarat, India The scientific community has widely supported wastewater monitoring of SARS-CoV-2 due to the early and prolonged excretion of coronavirus in the faecal matter. In the present study, eighteen influent wastewater samples from different wastewater treatment plants and pumping stations (5 samples from Vadodara city, 4 from Gandhinagar, and nine from Ahmedabad city) were collected and analyzed for the occurrence of SARS-CoV-2 RNA in Gujarat province, India. The results showed the highest SARS-CoV-2 genome concentration in Vadodara (3078 copies/ L), followed by Ahmedabad (2968 copies/ L) and Gandhinagar (354 copies/ L). The comparison of genome concentration more or less corresponded to the number of confirmed and active cases in all three cities. The study confirms the potential of the Surveillance of Wastewater for Early Epidemic Prediction (SWEEP) that can be used at a large scale around the globe for better dealing with the pandemic situation.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=132 SRC="FIGDIR/small/21254861v1_ufig1.gif" ALT="Figure 1">
View larger version (39K):
org.highwire.dtl.DTLVardef@142ae8aorg.highwire.dtl.DTLVardef@d10157org.highwire.dtl.DTLVardef@1af0dbdorg.highwire.dtl.DTLVardef@1af1b23_HPS_FORMAT_FIGEXP  M_FIG C_FIG


sentences: Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes The stepped wedge design is a type of unidirectional crossover design where cluster units switch from control to intervention condition at different pre-specified time points. While a convention in study planning is to assume the cluster-period sizes are identical, stepped wedge cluster randomized trials (SW-CRTs) involving repeated cross-sectional designs frequently have unequal cluster-period sizes, which can impact the efficiency of the treatment effect estimator. In this article, we provide a comprehensive investigation of the efficiency impact of unequal cluster sizes for generalized estimating equation analyses of SW-CRTs, with a focus on binary outcomes as in the Washington State Expedited Partner Therapy trial. Several major distinctions between our work and existing work include: (i) we consider multilevel correlation structures in marginal models with binary outcomes; (ii) we study the implications of both the between-cluster and within-cluster imbalances in sizes; and (iii) we provide a comparison between the independence working correlation versus the true working correlation and detail the consequences of ignoring correlation estimation in SW-CRTs with unequal cluster sizes. We conclude that the working independence assumption can lead to substantial efficiency loss and a large sample size regardless of cluster-period size variability in SW-CRTs, and recommend accounting for correlations in the analysis. To improve study planning, we additionally provide a computationally efficient search algorithm to estimate the sample size in SW-CRTs accounting for unequal cluster-period sizes, and conclude by illustrating the proposed approach in the context of the Washington State study.


sentences:
The impact of increasing the minimum legal drinking age to 20 years in Lithuania on all-cause mortality- an interrupted time-series analysis AimsTo determine the effect of an alcohol policy change, which increased the minimum legal drinking age (MLDA) from 18 years of age to 20 years of age on all-cause mortality rates in young adults in Lithuania.

MethodsAn interrupted time series analysis was conducted on a dataset from 2001 to 2019 (n = 228 months). The model tested the effects of the MLDA on all-cause mortality rates (deaths per 100,000 individuals) in 3 age categories (15-17 years old, 18-19 years old, 20-22 years old). Additional models that included GDP as a covariate and taxation policy were tested as well.

ResultsThere was a significant effect of the MLDA on all-cause mortality rates in those 18-19 years old, when modelled alone. Additional analyses controlling for the mortality rate of other age groups showed similar findings. Inclusion of confounding factors (policies on alcohol taxation, GDP) eliminated the effects of MLDA.

ConclusionsAlthough there was a notable decline in all-cause mortality rates among young adults in Lithuania, a direct causal impact of MLDA on all-cause mortality rates in young adults was not definitively found.

Short SummaryWe investigated the effect of an increase in minimum legal drinking age (MLDA) on all-cause mortality in young adults (aged 18-19). MLDA had a negative effect on all-cause mortality (even when controlling for mortality rates in other age groups), however when confounding factors were included, these effects were attenuated.


sentences:
Outward and inward protections of different mask designs for different respiratory activities We evaluate the outward and inward protections of different mask types (N95, surgical and two cloth mask designs) taking into account the imperfect fit on the wearer. To this end, we built a manikin to simulate exhaling, coughing and inhaling of aerosol droplets 0.3-5.0 {micro}m in diameters. The outward and inward protections depend on many factors, including the droplet size, the mask fit and the presence of a filter layer. Here, we show that cloth and surgical masks with a non-woven filter layer can achieve a combined outward and inward protections between 50% and 90%. Removing the filter layer greatly reduces the protection efficiency to below 20% for the smallest droplet size. While a well-fitted N95 masks offer protection efficiency close to 100%, a poorly fitted N95 mask with gaps offers less protection than a well-fitted surgical/cloth mask. We also found that double masking--the wearing of cloth mask on top of a surgical mask--is only effective at reducing outward droplet emissions when coughing, while offering no additional protection when exhaling/inhaling as compared to a single cloth/surgical mask. The results of our work can inform the implementation of mask mandates to minimize airborne transmissions of coronavirus disease of 2019 (COVID-19).

Practical implicationsO_LIA single cloth/surgical mask with non-woven filter layer offers significant protection against airborne transmissions.
C_LIO_LIFiltering facepiece masks such as N95 respirators are unlikely to achieve the advertised high protection for the general public due to poor mask fit.
C_LIO_LIDouble-masking offers little to no additional protection over a single cloth/surgical mask.
C_LI

labels: occupational and environmental health


sentences:
Carers using assistive technology in dementia care: an explanatory sequential mixed-methods study INTRODUCTIONInformal carers support persons with dementia to live at home, even with deteriorating physical and cognitive issues. The purpose of this explanatory sequential mixed methods study is to examine the experiences and impact of Assistive Technology (AT) on carers, providing care for a person with dementia.

METHODSThe quantitative phase was a survey carried out with carers of persons with dementia in the UK, who used AT. The qualitative phase involved in-depth telephone interviews with a purposive sample of survey respondents. Data was analysed using hermeneutic phenomenology to develop, compare and explain the findings of the survey.

RESULTSThe survey included data from 201 carers. Smartphones and tablet computers were the most frequently used AT. Multiple AT were used in the care of persons with dementia predominantly for safety, communication, and reminders. The Short Form-12 questions in the survey showed that carers in the 46-65 age group and carers who were not extremely satisfied with AT had lower mental component scores and carers who lived with the person with dementia and older carers had lower physical component scores. Twenty-three carers participated in the interviews, and 5 themes with 14 sub-themes were identified. The interviews helped confirm data from the survey on the impact of AT on the physical, mental and social wellbeing of the carers. It helped describe reasons for satisfaction with AT; how AT was used in daily life and strengthened caring relationships; and how wider support systems enhanced the care of a person with dementia using AT.

CONCLUSIONSThis study describes the use of AT in the real-world context. AT supplements the care provided to a person with dementia in the community. Appropriate use, access to AT and abilities of the carer can enhance the support provided through AT to both carers and the person with dementia.

labels: geriatric medicine


sentences:
North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness. ObjectiveTo assess the early vaccine administration coverage and vaccine effectiveness and outcome data across an integrated care system of eight CCGs leveraging a unique population-level care dataset

DesignRetrospective cohort study.

SettingIndividuals eligible for COVID 19 vaccination in North West London based on linked primary and secondary care data.

Participants2,183,939 individuals eligible for COVID 19 vaccination

ResultsDuring the NWL vaccine programme study time period 5.88% of individuals declined and did not receive a vaccination. Black or black British individuals had the highest rate of declining a vaccine at 16.14% (4,337). There was a strong negative association between deprivation and rate of declining vaccination (r=-0.94, p<0.01) with 13.5% of individuals declining vaccination in the most deprived postcodes compared to 0.98% in the least deprived postcodes.

In the first six days after vaccination 344 of 389587 individuals tested positive for COVID-19 (0.09%). The rate increased to 0.13% (525/389,243) between days 7 and 13, before then gradually falling week on week.

At 28 days post vaccination there was a 74% (HR 0.26 (0.19-0.35)) and 78% (HR 0.22 (0.18-0.27)) reduction in risk of testing positive for COVID-19 for individuals that received the Oxford/Astrazeneca and Pfizer/BioNTech vaccines respectively, when compared with unvaccinated individuals.

After vaccination very low rates of hospital admission were seen in individuals testing positive for COVID-19 (0.01% of all patients vaccinated).

ConclusionsThis study provides further evidence that a single dose of either the Pfizer/BioNTech vaccine or the Oxford/Astrazeneca vaccine is effective at reducing the risk of testing positive for COVID-19 up to 60 days across all adult age groups, ethnic groups, and risk categories in an urban UK population. There was no difference in effectiveness up to 28 days between the Oxford/Astrazeneca and Pfizer/BioNtech vaccines.

In those declining vaccination higher rates were seen in those living in the most deprived areas and in Black and Black British groups.

There was no definitive evidence to suggest COVID-19 was transmitted as a result of vaccination hubs during vaccine the administration roll-out in NWL, and the risk of contracting COVID-19 and/or becoming hospitalised after vaccination has been demonstrated to be very low in the vaccinated population.


sentences:
Optimal policy determination in sequential systemic and locoregional therapy of oropharyngeal squamous carcinomas: A patient-physician digital twin dyad with deep Q-learning for treatment selection. PurposeCurrently, selection of patients for sequential vs. concurrent chemotherapy/radiation regimens lacks evidentiary support, and it is based on locally-optimal decisions for each step. We aim to optimize the multi-step treatment of head and neck cancer patients and to predict multiple patient survival and toxicity outcomes, and we develop, apply, and evaluate a first application of deep-Q-learning (DQL) and simulation to this problem.

Patients and methodsThe treatment decision DQL digital twin and the patients digital twin were created, trained and evaluated on a dataset of 536 oropharyngeal squamous cell carcinoma (OPC) patients with the goal of, respectively, determining the optimal treatment decisions with respect to survival and toxicity metrics, and predicting the outcomes of the optimal treatment on the patient. The models were trained on a subset of 402 patients (split randomly) and evaluated on a separate set of 134 patients. Training and evaluation of the digital twin dyad was completed in August 2020. The dataset includes 3-step sequential treatment decisions and complete relevant history of the patients cohort treated at MD Anderson Cancer Center between 2005 and 2013, with radiomics analysis performed for the segmented primary tumor volumes.

ResultsOn the validation set, 87.09% mean and 90.85% median accuracy in treatment outcome prediction, matching the clinicians outcomes and improving (predicted) survival rate by +3.73% (95% CI: [-0.75%, +8.96%]), and dysphagia rate by +0.75% (CI: [-4.48%, +6.72%]) when following DQL treatment decisions.

ConclusionGiven the prediction accuracy and predicted improvement on medically relevant outcomes yielded by this approach, this digital twin dyad of the patient-physician dynamic treatment problem has the potential of aiding physicians in determining the optimal course of treatment and in assessing its outcomes.


sentences:
Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine? - Approximating the funding to the University of Oxford for the research and development of the ChAdOx vaccine technology ObjectivesThe Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19 or Vaxzevira) builds on nearly two decades of research and development (R&D) into Chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aims to approximate the funding for the R&D of the ChAdOx technology and the Oxford-AstraZeneca vaccine, and assess the transparency of funding reporting mechanisms.

DesignWe conducted a scoping review and publication history analysis of the principal investigators to reconstruct the funding for the R&D of the ChAdOx technology. We matched award numbers with publicly-accessible grant databases. We filed Freedom Of Information (FOI) requests to the University of Oxford for the disclosure of all grants for ChAdOx R&D.

ResultsWe identified 100 peer-reviewed articles relevant to ChAdOx technology published between 01/2002 and 10/2020, extracting 577 mentions of funding bodies from funding acknowledgement statements. Government funders from overseas were mentioned 158 (27.4%), the U.K. government 147 (25.5%) and charitable funders 138 (23.9%) times. Grant award numbers were identified for 215 (37.3%) mentions, amounts were available in the public realm for 121 (21.0%) mentions. Based on the FOIs, until 01/2020, the European Commision (34.0%), Wellcome Trust (20.4%) and CEPI (17.5%) were the biggest funders of ChAdOx R&D. From 01/2020, the U.K. Department of Health and Social Care was the single largest funder (89.3%). The identified R&D funding was {pound}104,226,076 reported in the FOIs, and {pound}228,466,771 reconstructed from the literature search.

ConclusionsOur study identified that public funding accounted for 97.1-99.0% of the funding towards the R&D of ChAdOx and the Oxford-AstraZeneca vaccine. We furthermore encountered a severe lack of transparency in research funding reporting mechanisms.

Strengths and limitations of this studyO_LIThis is the first study that analysed the R&D funding and funders contributing to the Oxford-AstraZeneca vaccine and the underlying ChAdOx technology.
C_LIO_LIWe used multiple sources and methods to approximate the R&D funding of the Oxford-AstraZeneca Vaccine and ChAdOx technology.
C_LIO_LIWe cross-matched award numbers with all publicly-accessible databases by major funders of R&D.
C_LIO_LIFreedom Of Information requests were a useful method to identify R&D funding, but face limitations in their scope of data collection.
C_LIO_LIIntegration of the two data sets was not possible due to insufficient grant information and lack of award numbers in funding acknowledgement statements in peer-reviewed articles.
C_LI

labels: health policy


sentences:
Impact of the COVID-19 pandemic and response on the utilisation of health services during the first wave in Kinshasa, the Democratic Republic of the Congo IntroductionHealth service use among the general public can decline during infectious disease outbreaks and has been predicted among low and middle-income countries during the COVID-19 pandemic. In March 2020, the government of the Democratic Republic of the Congo (DRC) implemented public health measures across Kinshasa, including strict lockdown measures in the Gombe health zone, to mitigate impact of the pandemic.

MethodsUsing data from the Health Management Information System (January 2018 - December 2020), we evaluated the impact of the pandemic on the use of essential health services (total visits, maternal health, vaccinations, visits for common infectious diseases, and diagnosis of non-communicable diseases) using interrupted time series with mixed effects segmented Poisson regression models during the first wave of the pandemic. Analyses were stratified by age, sex, health facility, and neighbourhood.

ResultsHealth service use dropped rapidly following the start of the pandemic and ranged from 16% for hypertension diagnoses to 39% for diabetes diagnoses. However, reductions were highly concentrated in Gombe (81% decline in total visits) relative to health zones without lockdown. When the lockdown was lifted, total visits, visits for infectious diseases, and diagnoses for non-communicable diseases increased approximately two-fold. Hospitals were more affected than health centres. Overall, the use of maternal health services and vaccinations was not significantly affected.

ConclusionThe COVID-19 pandemic resulted in important reductions in health service utilisation in Kinshasa, particularly Gombe. Lifting of lockdown led to a rebound in the level of health service use but it remained lower than pre-pandemic levels.

Summary BoxO_ST_ABSWhat is already known about this subjectC_ST_ABSO_LISubstantial declines in the use of health services among the general public have been well-documented during previous outbreaks of infectious diseases.
C_LIO_LIModelled studies predicted substantial increases in morbidity and mortality in many low- and middle-income countries (LMICs) mainly due to expected declines in the use of health services among the general public.
C_LIO_LIOnly a small number of studies have so far evaluated the impact of the COVID-19 pandemic on the use of health services in LMICs and none have also evaluated both the implementation and lifting of lockdown measures.
C_LI

What are the new findingsO_LIThis study found that overall use of health services declined in Kinshasa but was most pronounced in the Gombe health zone which was subject to strict lockdown measures.
C_LIO_LISome health services were more affected than others, most notably visits and tests for malaria and visits for new diagnoses of non-communicable diseases. Maternal and child health services were relatively unaffected.
C_LIO_LIWhen the lockdown measures were lifted, health service utilization rebounded but remained at levels lower than those observed pre-pandemic.
C_LI

What do the new findings implyO_LIThe COVID-19 pandemic has likely had important effects on the use of health services among the general public throughout LMICs. However, evidence from Kinshasa suggests the effects may not be as widespread as previously assumed.
C_LIO_LIThe impact of strict social distancing measures needs on COVID-19 outcomes needs to be weighed off against the potential population-level health effects of these policies in various international contexts.
C_LI


sentences: Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients Many new aspects of COVID-19 disease, including different clinical manifestations, have been identified during the pandemic. The wide array of symptoms and variation in disease severity after SARS-CoV-2 infection might be related to heterogeneity in the immune responses of different patients. Here we describe a new method for a simple multi-antigen serological test that generates a full picture of seroconversion in a single reaction. The assay is based on the detection by flow cytometry of multiple immunoglobulin classes (isotypes) specific for four SARS-CoV-2 antigens: the Spike glycoprotein (one of the highly immunogenic proteins), its RBD fragment (the major target for neutralising antibodies), the nucleocapsid protein and the main cysteine-like protease. Until now, most diagnostic serological tests measured antibodies to only one antigen and some patients seemed to not make any antibody response. Our data reveal that while most patients respond against all the viral antigens tested, others show a marked bias to make antibodies against either proteins exposed on the viral particle or those released after cellular infection. Combining all the four antigens and using machine learning techniques, it was possible to clearly discriminate between patients and healthy controls with 100% confidence. Further, combination of antigens and different immunoglobulin isotypes in this multi-antigen assay improved the classification of patients with mild and severe disease. Introduction of this method will facilitate massive screenings of patients to evaluate their immune response. It could also support vaccination campaigns both to select non-immune individuals and to distinguish infected patients from vaccine responders.


sentences: Variant Creutzfeldt-Jakob Disease: The Challenge of Preventing a Rare but Potentially Devastating Exposure Although rare, patients with variant Creutzfeldt-Jakob Disease (vCJD) in their differential diagnosis of progressive dementia and movement disorder could continue to present to hospitals for care. However, U.S.-based infection control guidelines do not fully address the possibility of vCJD. After near-misses involving increasing numbers of patients with clinical findings and epidemiologic risks compatible with vCJD, or exposures to chronic wasting disease, we sought to improve recognition and prevention of iatrogenic spread of these prion-related diseases.


sentences:
Direct and indirect effectiveness of mRNA vaccination against SARS-CoV-2 infection in long-term care facilities in Spain ObjectivesTo estimate indirect and total (direct plus indirect) effects of COVID-19 vaccination in residents in long-term care facilities (LTCF).

DesignRegistries-based cohort study including all residents in LTCF [≥]65 years offered vaccination between 27 December 2020 and 10 March 2021. Risk of SARS-CoV-2 infection following vaccination was compared with the risk in the same individuals in a period before vaccination. Risk in non-vaccinated was also compared to a period before the vaccination programme to estimate indirect protection. Standardized cumulative risk was computed adjusted by previous documented infection (before the start of follow-up) and daily-varying SARS-CoV-2 incidence and reproductive number.

Participants573,533 records of 299,209 individuals in the National vaccination registry were selected; 99.0% had [≥]1 vaccine-dose, 99.8% was Pfizer/BioNTech (BNT162b2). Residents mean age was 85.9, 70.9% were females. A previous SARS-CoV-2 infection was found in around 25% and 13% of participants, respectively, at the time of vaccine offer and in the reference period.

Main outcome measuresDocumented SARS-CoV-2 infection identified in the National COVID-19 laboratory registry.

ResultsTotal VE was 57.2% (95% Confidence Interval: 56.1%-58.3%), and was highest [≥]28 days after the first vaccine-dose (proxy of [≥]7 days after the second dose) and for individuals naive to SARS-CoV-2 [81.8% (81.0%-82.7%)] compared to those with previous infection [56.8% (47.1%-67.7%)]. Vaccination prevented up to 9.6 (9.3-9.9) cases per 10.000 vaccinated per day; 11.6 (11.3-11.9) if naive vs. 0.8 (0.5-1.0) if previous infection. Indirect protection in the non-vaccinated could only be estimated for naive individuals, at 81.4% (73.3%-90.3%) and up to 12.8 (9.4-16.2) infections prevented per 10.000 indirectly protected per day.

ConclusionsOur results confirm the effectiveness of mRNA vaccination in institutionalized elderly population, endorse the policy of universal vaccination in this setting, including in people with previous infection, and suggest that even non-vaccinated individuals benefit from indirect protection.

Key messagesO_LICOIVD-19 vaccination reduced the risk of documented SARS-CoV-2 infection in institutionalized elderly by 57.2% (56.1% to 58.3%), which increased to 81.2% (80.2% to 82%) for the fully vaccinated.
C_LIO_LIIn individuals naive to SARS-CoV-2 vaccination reduced the risk by up to 81.8% and averted up to 11.6 cases per 10,000 vaccinated persons per day.
C_LIO_LIThose with previous infection also benefited from a risk reduction of 57%, which translated in less than 1 infection averted per 10,000 vaccinated persons per day.
C_LIO_LINon-vaccinated individuals living in facilities where the majority (residents and staff) had been vaccinated showed a risk reduction similar to those actually vaccinated.
C_LI


sentences:
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia BackgroundSevere malaria and invasive non-typhoidal Salmonella (NTS) are life-threatening infections that often co-exist in African children. The iron-regulatory hormone hepcidin is highly upregulated during malaria and controls the availability of iron, a critical nutrient for bacterial growth, within the Salmonella-containing vacuole.

MethodsWe first investigated the relationship between Plasmodium falciparum malaria and NTS bacteremia in all pediatric admissions aged [≤]5 years between August 1998 and October 2019 (n=75,015). We then assayed hepcidin and measures of iron status in five groups: (1) children with concomitant severe malaria anemia (SMA) and NTS (SMA+NTS, n=16); and in matched children with (2) SMA alone (n=33); (3) NTS alone (n=33); (4) cerebral malaria (CM, n=34); and (5) community-based children.

ResultsIn hospitalized children SMA, but not other malaria phenotypes, was associated with an increased risk of NTS (adjusted OR 2.88 [95% CI 1.97, 4.23]; P<0.0001). Risk of NTS increased by 30% with each 1g/dl decrease in hemoglobin concentrations. In hospitalized children median hepcidin levels were lower in the SMA+NTS (9.3 ng/mL [interquartile range 4.7, 49.8]) and SMA (31.1 ng/mL [5.5, 61.2]) groups, compared to levels in those with CM (90.7 ng/mL [38.7, 176.1]) or NTS (105.8 ng/mL [17.3, 233.3]), despite similar ferritin and CRP levels. Soluble transferrin receptor levels were lower in the CM group compared to the other hospitalized groups.

ConclusionSMA was associated with increased risk of NTS and with reduced hepcidin levels. We hypothesized that reduced hepcidin might allow increased movement of iron into the Salmonella-containing vacuole favoring bacterial growth.


sentences:
Modelling the impact of extending dose intervals for COVID-19 vaccines in Canada BackgroundDual dose SARS-CoV-2 vaccines demonstrate high efficacy and will be critical in public health efforts to mitigate the COVID-19 pandemic and its health consequences; however, many jurisdictions face very constrained vaccine supply. We examined the impacts of extending the interval between two doses of mRNA vaccines in Canada in order to inform deliberations of Canadas National Advisory Committee on Immunization.

MethodsWe developed an age-stratified, deterministic, compartmental model of SARS-CoV-2 transmission and disease to reproduce the epidemiologic features of the epidemic in Canada. Simulated vaccination comprised mRNA vaccines with explicit examination of effectiveness against disease (67% [first dose], 94% [second dose]), hospitalization (80% [first dose], 96% [second dose]), and death (85% [first dose], 96% [second dose]) in adults aged 20 years and older. Effectiveness against infection was assumed to be 90% relative to the effectiveness against disease. We used a 6-week mRNA dose interval as our base case (consistent with early program rollout across Canadian and international jurisdictions) and compared extended intervals of 12 weeks, 16 weeks, and 24 weeks. We began vaccinations on January 1, 2021 and simulated a third wave beginning on April 1, 2021.

ResultsExtending mRNA dose intervals were projected to result in 12.1-18.9% fewer symptomatic cases, 9.5-13.5% fewer hospitalizations, and 7.5-9.7% fewer deaths in the population over a 12-month time horizon. The largest reductions in hospitalizations and deaths were observed in the longest interval of 24 weeks, though benefits were diminishing as intervals extended. Benefits of extended intervals stemmed largely from the ability to accelerate coverage in individuals aged 20-74 years as older individuals were already prioritized for early vaccination. Conditions under which mRNA dose extensions led to worse outcomes included: first-dose effectiveness < 65% against death; or protection following first dose waning to 0% by month three before the scheduled 2nd dose at 24-weeks. Probabilistic simulations from a range of likely vaccine effectiveness values did not result in worse outcomes with extended intervals.

ConclusionUnder real-world effectiveness conditions, our results support a strategy of extending mRNA dose intervals across all age groups to minimize symptomatic cases, hospitalizations, and deaths while vaccine supply is constrained.


sentences: Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Convalescent Plasma Hesitancy cost lives? The US Food and Drug Administration (FDA) authorized treatment of hospitalized COVID-19 patients with Convalescent Plasma (CCP) via the Expanded Access Program (EAP) and the Emergency Use Authorization (EUA), leading to the use of CCP in some 500,000 patients during the first year of the pandemic. We tracked the number of CCP units dispensed to hospitals by blood banking organizations and correlated that usage with hospital admission and mortality data over the course of the year. CCP usage per admission peaked after issuance of the EUA, with more than 40% of inpatients estimated to have received CCP between late September and early November 2020. However, following reports of randomized controlled trials that failed to show clear benefit from CCP, usage/admissions declined steadily to a nadir of less than 10% in March 2021. We found a strong inverse correlation (Pearsons correlation coefficient of -0.5176 with P = 0.00242) between CCP usage/hospital admission and deaths occurring two weeks after admission, and this finding was robust to examination of deaths taking place one, two or three weeks after admission. Changes in the number of hospital admissions, prevalence of variants, and age of patients could not explain these findings. We estimate that the retreat from CCP usage, a phenomenon we termed  plasma hesitancy, might have resulted in 29,000 to 36,000 excess deaths in the period from mid-November 2020 to February 2021. These results highlight the need for additional studies to ascertain the variables associated with efficacy and/or provide other explanations for the robust relationships observed in this study.


sentences:
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States BackgroundMonoclonal antibodies (mAbs) against SARS-CoV-2 are a promising treatment for limiting the progression of COVID-19 and decreasing strain on hospitals. Their use, however, remains limited, particularly in disadvantaged populations.

MethodsElectronic health records were reviewed from SARS-CoV-2 patients at a single medical center in the United States that initiated mAb infusions in January 2021 with the support of the U.S. Department of Health and Human Services National Disaster Medical System. Patients who received mAbs were compared to untreated patients from the time period before mAb availability who met eligibility criteria for mAb treatment. We used logistic regression to measure the effect of mAb treatment on the risk of hospitalization or emergency department (E.D.) visit within 30 days of laboratory-confirmed COVID-19.

ResultsOf 598 COVID-19 patients, 270 (45%) received bamlanivimab and 328 (55%) were untreated. Two hundred and thirty-one patients (39%) were Hispanic. Among treated patients, 5/270 (1.9%) presented to the E.D. or required hospitalization within 30 days of a positive SARS-CoV-2 test, compared to 39/328 (12%) untreated patients (p<0.001). After adjusting for age, gender, and comorbidities, the risk of E.D. visit or hospitalization was 82% lower in mAb-treated patients compared to untreated patients (95% confidence interval [CI]: 66%-94%).

ConclusionsIn this diverse, real-world COVID-19 patient population, mAb treatment significantly decreased the risk of subsequent E.D. visit or hospitalization. Broader treatment with mAbs, including in disadvantaged patient populations, can decrease the burden on hospitals and should be facilitated in all populations in the United States to ensure health equity.

SummaryIn a diverse, real-world COVID-19 patient population, treatment with monoclonal antibodies significantly decreased the risk of subsequent emergency department visit or hospitalization within 30 days of a positive SARS-CoV-2 viral test.

labels: epidemiology


sentences:
Early evidence of COVID-19 vaccine effectiveness within the general population of California BackgroundEstimates of COVID-19 vaccine effectiveness under real-world conditions, and understanding of barriers to uptake, are necessary to inform vaccine rollout.

MethodsWe enrolled cases (testing positive) and controls (testing negative) from among the population whose SARS-CoV-2 molecular diagnostic test results from 24 February-29 April 2021 were reported to the California Department of Public Health. Participants were matched on age, sex, and geographic region. We assessed participants self-reported history of COVID-19 vaccine receipt (BNT162b2 and mRNA-1273). Participants were considered fully vaccinated two weeks after second dose receipt. Among unvaccinated participants, we assessed willingness to receive vaccination, when eligible. We measured vaccine effectiveness (VE) via the matched odds ratio of prior vaccination, comparing cases with controls.

ResultsWe enrolled 1023 eligible participants aged [≥]18 years. Among 525 cases, 71 (13.5%) received BNT162b2 or mRNA-1273; 20 (3.8%) were fully vaccinated with either product. Among 498 controls, 185 (37.1%) received BNT162b2 or mRNA-1273; 86 (16.3%) were fully vaccinated with either product. Two weeks after second dose receipt, VE was 86.8% (95% confidence interval: 68.6-94.7%) and 85.6% (69.1-93.9%) for BNT162b2 and mRNA-1273, respectively. Fully vaccinated participants receiving either product experienced 91.3% (79.7-96.3%) and 68.3% (28.5-86.0%) VE against symptomatic and asymptomatic infection, respectively. Among unvaccinated participants, 42.4% (159/375) residing in rural regions and 23.8% (67/281) residing in urban regions reported hesitancy to receive COVID-19 vaccination.

ConclusionsAuthorized mRNA vaccines are effective at reducing documented SARS-CoV-2 infections within the general population of California. Vaccine hesitancy presents a barrier to reaching coverage levels needed for herd immunity.

Brief pointsO_LIVaccination is preventing documented SARS-CoV-2 infection in California, with 68% and 91% effectiveness against asymptomatic and symptomatic infection, respectively.
C_LIO_LIVaccine effectiveness was equivalent for BNT126b2 and mRNA-1273.
C_LIO_LIOnly 66% of unvaccinated participants were willing to receive the vaccine when eligible.
C_LI


sentences: Estimating COVID-19 infection fatality rate in Mumbai during 2020 The aim of this piece is to provide estimates of the infection fatality rate (IFR) of COVID-19 in Mumbai during 2020, namely the fraction of SARS-CoV-2 infections which resulted in death. Estimates are presented for slums and nonslum areas, and for the city as a whole. These are based largely on the citys official COVID-19 fatality data, seroprevalence data, and all-cause mortality data. Using recorded COVID-19 fatalities in the numerator, we obtain IFR estimates of 0.13%-0.17%. On the other hand, using excess deaths we obtain IFR estimates of 0.28%-0.40%. The estimates based on excess deaths are broadly consistent with the citys age structure, and meta-analyses of COVID-19 age-stratified IFR. If excess deaths were largely from COVID-19, then only around half of COVID-19 deaths were officially recorded in the city. The analysis indicates that levels of excess mortality in excess deaths per 1000 population were similar in the citys slums and nonslum areas. On the other hand the estimated ratio of excess deaths to official COVID-19 deaths in the slums was much higher than in nonslum areas, suggesting much weaker COVID-19 death reporting from the slums.


sentences:
DNA methylation and brain dysmaturation in preterm infants Preterm birth is associated with dysconnectivity of structural brain networks and is a leading cause of neurocognitive impairment in childhood. Variation in DNA methylation (DNAm) is associated with early exposure to extrauterine life but there has been little research exploring its relationship with brain development.

Using genome-wide DNA methylation data from saliva of 258 neonates, we investigated the impact of gestational age on the methylome and performed functional analysis to identify enriched gene sets from probes that contributed to differentially methylated probes (DMPs) or regions (DMRs). We tested the hypothesis that variation in DNAm could underpin the association between preterm birth and atypical brain development by linking DMPs with measures of white matter connectivity derived from diffusion MRI metrics: peak width of skeletonised mean diffusivity (PSMD), fractional anisotropy (PSFA) and neurite density index (PSNDI).

Gestational age at birth was associated with widespread differential methylation, with genome-wide significant associations observed for 8,870 CpG probes (p<3.6x10-8) and 1,767 differentially methylated regions. Functional analysis identified 14 enriched gene ontology terms pertaining to cell-cell contacts and cell-extracellular matrix contacts. Principal component analysis of probes with genome-wide significance revealed a first principal component (PC1) that explained 23.5% of variance in DNAm, and this was negatively associated with gestational age at birth. PC1 was associated with PSMD ({beta}=0.349, p=8.37x10-10) and PSNDI ({beta}=0.364, p=4.15x10-5), but not with PSFA ({beta}=-0.035, p=0.510); these relationships mirrored the imaging metrics associations with gestational age at birth.

Gestational age at birth has a profound and widely distributed effect on the neonatal saliva methylome. Enriched gene ontology terms related to cell-cell contacts reveal pathways that could mediate the effect of early life environmental exposures on development. Finally, associations between differential DNAm and image markers of white matter tract microstructure suggest that variation in DNAm may provide a link between preterm birth and the dysconnectivity of developing brain networks that characterises atypical brain development in preterm infants.

labels: pediatrics


sentences: Public health impacts of an imminent Red Sea oil spill The possibility of a massive oil spill in the Red Sea is increasingly likely. The Safer, a deteriorating oil tanker containing 1.1 million barrels of oil, has been deserted near the coast of Yemen since 2015, and threatens environmental catastrophe to a country presently in a humanitarian crisis. Here, we model the immediate public health impacts of a simulated spill. We estimate all of Yemens imported fuel through its key Red Sea ports would be disrupted, and that the anticipated spill could disrupt clean water supply equivalent to the daily use of 9 to 9.9 million people, food supply for 5.7 to 8.4 million people, and 93% to 100% of Yemens Red Sea fisheries. We also estimate an increased risk of cardiovascular hospitalization from pollution ranging from 5.8% to 42.0% over the duration of the spill. The spill and its potentially disastrous impacts remain entirely preventable through offloading the oil. Our results stress the need for urgent action to avert this looming disaster.

labels: public and global health


sentences: Involvement of the habenula in the pathophysiology of autism spectrum disorder. The habenula is a small epithalamic structure that has rich widespread connections to multiple cortical, subcortical and brainstem regions. It has been identified as the central structure modulating the reward value of social interactions, behavioral adaptation, sensory integration and circadian rhythm. Autism spectrum disorder is characterized by social communication deficits, restricted interests and repetitive behaviors, and frequently associated with altered sensory perception and mood and sleep disorders. The habenula is implicated in all these behaviors and results of preclinical studies suggest a possible involvement of the habenula in the pathophysiology of this disorder. Using anatomical magnetic resonance imaging and automated segmentation we show that the habenula is significantly enlarged in children and adults with ASD compared to age matched controls. The present study is first to provide evidence of the involvement of the Hb in the pathophysiology of ASD.

labels: radiology and imaging


sentences:
Changing patterns of sickness absence among healthcare workers in England during the COVID-19 pandemic. ObjectiveTo explore impacts of the COVID-19 pandemic on patterns of sickness absence among staff employed by the National Health Service (NHS) in England.

MethodsWe analysed prospectively collected, pseudonymised data on 959,356 employees who were continuously employed by NHS trusts during 1 January 2019 to 31 July 2020, comparing the frequency of new sickness absence in 2020 with that at corresponding times in 2019.

ResultsAfter exclusion of episodes directly related to COVID-19, the overall incidence of sickness absence during the initial 10 weeks of the pandemic (March-May 2020) was more than 20% lower than in corresponding weeks of 2019, but trends for specific categories of illness varied. Marked increases were observed for asthma (122%), infectious diseases (283%) and mental illness (42.3%), while reductions were apparent for gastrointestinal problems (48.4%), genitourinary/gynaecological disorders (33.8%), eye problems (42.7%), injury and fracture (27.7%), back problems (19.6%), other musculoskeletal disorders (29.3%), disorders of ear, nose and throat (32.7%), cough/flu (24.5%) and cancer (24.1%). A doubling of new absences for pregnancy-related disorders during 18 May to 19 July of 2020 was limited to women with earlier COVID-19 sickness absence.

ConclusionsVarious factors will have contributed to the large and divergent changes that were observed. The findings add to concerns regarding delays in diagnosis and treatment of cancers, and support a need to plan for a large backlog of treatment for many other diseases. Further research should explore the rise in absence for pregnancy-related disorders among women with earlier COVID-19 sickness absence.

O_TEXTBOX1. What is already known about this subject?

Historically, rates of sickness absence among the NHS workforce in England have been relatively high but stable. Reports of a marked increase during the first wave of the COVID-19 pandemic have not distinguished between different categories of underlying illness.

2. What are the new findings?

During the first wave of COVID-19, incidence of sickness-absence changed markedly when compared to the previous year, with major increases for some categories of illness, and large declines for many others, including cancer.

3. How might this impact on policy or clinical practice in the foreseeable future?

The findings support a need to plan for effects from delayed diagnosis and treatment of cancer, and to manage a large backlog of treatment for many other diseases.

C_TEXTBOX


sentences:
Development of a tool to prioritize the monitoring of COVID-19 patients by public health teams BackgroundIn the context of the COVID-19 pandemic, public health teams have struggled to conduct monitoring for confirmed or suspicious COVID-19 patients. However, monitoring these patients is critical to improving the chances of survival, and therefore, a prioritization strategy for these patients is warranted. This study developed a monitoring algorithm for COVID-19 patients for the Colombian Ministry of Health and Social Protection (MOH).

MethodsThis work included 1) a literature review, 2) consultations with MOH and National Institute of Health officials, and 3) data analysis of all positive COVID-19 cases and their outcomes. We used clinical and socioeconomic variables to develop a set of risk categories to identify severe cases of COVID-19.

ResultsThis tool provided four different risk categories for COVID-19 patients. As soon as the time of diagnosis, this tool can identify 91% of all severe and fatal COVID-19 cases within the first two risk categories.

ConclusionThis tool is a low-cost strategy to prioritize patients at higher risk of experiencing severe COVID-19. This tool was developed so public health teams can focus their scarce monitoring resources on individuals at higher mortality risk. This tool can be easily adapted to the context of other lower and middle-income countries. Policymakers would benefit from this low-cost strategy to reduce COVID-19 mortality, particularly during outbreaks.


sentences:
Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment SARS-CoV-2 Variants of Concerns (VOC), e.g., B.1.351 (20H/501Y.V2) and P1 (20J/501Y.V3), harboring N-terminal domain (NTD) or the receptor-binding domain (RBD) (e.g., E484K) mutations, exhibit reduced in vitro susceptibility to convalescent serum, commercial antibody cocktails, and vaccine neutralization, and have been associated with reinfection. The accumulation of these mutations could be the consequence of intra-host viral evolution due to prolonged infection in immunocompromised hosts. In this study, we document the microevolution of SARS-CoV-2 recovered from sequential tracheal aspirates from an immunosuppressed patient on tacrolimus, steroids and convalescent plasma therapy, and identify the emergence of multiple NTD and RBD mutations associated with reduced antibody neutralization as early as three weeks after infection. SARS-CoV-2 genomes from the first swab (Day 0) and three tracheal aspirates (Day 7, 21 and 27) were compared at the sequence level. We identified five different S protein mutations at the NTD or RBD regions from the second tracheal aspirate sample (21 Day). The S:Q493R substitution and S:243-244LA deletion had [~]70% frequency, while ORF1a:A138T, S:141-144LGVY deletion, S:E484K and S:Q493K substitutions demonstrated [~]30%, [~]30%, [~]20% and [~]10% mutation frequency, respectively. However, the third tracheal aspirate sample collected one week later (Day 27) was predominated by the haplotype of ORF1a:A138T, S:141-144LGVY deletion and S:E484K (> 95% mutation frequency). Notably, S protein deletions (141-144LGVY and 243-244LA deletions in NTD region) and substitutions (Q493K/R and E484K in the RBD region) previously showed reduced susceptibly to monoclonal antibody or convalescent plasma. The observation supports the hypothesis that VOCs can independently arise and that immunocompromised patients on convalescent plasma therapy are potential breeding grounds for immune-escape mutants.

Competing Interest StatementThe authors have declared no competing interest.

Funding StatementThe study was in part supported by Center for Discovery and Innovation and Hackensack Meridian Health Foundation.

labels: infectious diseases


sentences:
Accuracy of antigen and nucleic acid amplification testing on saliva and naopharyngeal samples for detection of SARS-CoV-2 in ambulatory care BackgroundNasopharyngeal sampling for nucleic acid amplification testing (NAAT) is the current standard diagnostic test for of coronavirus disease 2019 (COVID-19). However, the NAAT technique is lengthy and nasopharyngeal sampling requires trained personnel. Saliva NAAT represents an interesting alternative but diagnostic performances vary widely between studies.

ObjectiveTo assess the diagnostic accuracy of a nasopharyngeal point-of-care antigen (Ag) test and of saliva NAAT for detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), as compared to nasopharyngeal NAAT.

DesignProspective participant enrollment from 19 October through 18 December 2020.

SettingTwo community COVID-19 screening centers in Paris, France.

Participants1452 ambulatory children and adults referred for SARS-CoV-2 testing.

InterventionsNAAT on a saliva sample (performed with three different protocols for pre-processing, amplification and detection of SARS-CoV-2) and Ag testing on a nasopharyngeal sample.

MeasurementsPerformance of saliva NAAT and nasopharyngeal Ag testing.

ResultsOverall, 129/1443 (9%) participants tested positive on nasopharyngeal NAAT (102/564 [18%] in symptomatic and 27/879 [3%] in asymptomatic participants). Sensitivity was of 94% (95% CI, 86% to 98%), 23% (CI, 14% to 35%), 94% (CI, 88% to 97%) and 96% (CI, 91% to 99%) for the nasopharyngeal Ag test and the three different protocols of saliva NAAT, respectively. Estimates of specificity were above 95% for all methods. Diagnostic accuracy was similar in symptomatic and asymptomatic individuals.

LimitationsFew children (n=122, 8%) were included.

ConclusionIn the ambulatory setting, diagnostic accuracy of nasopharyngeal Ag testing and of saliva NAAT seems similar to that of nasopharyngeal NAAT, subject to strict compliance with specific pre-processing and amplification protocols.

Registration numberNCT04578509

Funding SourcesFrench Ministry of Health and the Assistance Publique-Hopitaux de Paris Foundation.